PubMed · 2004 · 189 citations · 7 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyPharmacovigilanceTuberculosis ControlAdverse Drug Event PreventionAdverse Drug Event ReportingAdverse Drug Reaction MonitoringAdverse Drug Reaction ReportingTuberculosis CareTuberculosis PharmacotherapyMultidrug-resistant Tuberculosis TreatmentSecond-line ChemotherapyTuberculosis Drug ResistanceTuberculosis Treatment Regimens
Adverse events associated with second-line drugs have been mentioned as obstacles in the management of multidrug-resistant tuberculosis (MDR-TB). Data on adverse events were collected from five DOTS-Plus sites in Estonia, Latvia, Peru (Lima), the Philippines (Manila) and the Russian Federation (Tomsk Oblast). The results show that among 818 patients enrolled on MDR-TB treatment only 2% of patients stopped treatment, but 30% required removal of the suspected drug(s) from the regimen due to adverse events. The study shows that adverse events are manageable in the treatment of MDR-TB in resource-limited settings provided that standard management strategies are applied.
7
The Treatment of Multidrug-Resistant Tuberculosis in Turkey
Kemal Tahaoğlu, Tülay Törün, Tülin Sevim et al. · New England Journal of Medicine · 2001 · 250 citations · Full text